Convatec Group PLC (CNVVF)

Market Cap	5.68B -17.1%
Revenue (ttm)	2.44B +6.6%
Net Income	175.00M -8.4%
EPS	0.09 -7.5%
Shares Out	n/a
PE Ratio	32.45
Forward PE	14.20
Dividend	0.06 (1.72%)
Ex-Dividend Date	Apr 16, 2026

Volume	7,392
Average Volume	101,116
Open	3.650
Previous Close	3.356
Day's Range	3.400 - 3.650
52-Week Range	2.780 - 3.950
Beta	0.76
RSI	55.77
Earnings Date	Aug 4, 2026

About Convatec Group

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorect...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1978
• Employees: 10,910
• Stock Exchange: OTCMKTS
• Ticker Symbol: CNVVF

Financial Performance

In 2025, Convatec Group's revenue was $2.44 billion, an increase of 6.55% compared to the previous year's $2.29 billion. Earnings were $175.00 million, a decrease of -8.38%.